Status:
COMPLETED
Evaluation of Extended Wear Technology
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Evaluating the efficacy and effectiveness of an advancement in the fitting characteristics of extended wear technology with the commercially available device as a comparator.
Detailed Description
A interventional study in which participants will be fit with the commercially available device in one ear and the experimental device in the opposite ear. After two weeks, the devices will be switche...
Eligibility Criteria
Inclusion
- Mild, Moderate and Moderate Severe Hearing loss
- Previous extended wear technology users who rejected or cancelled trials due to discomfort, feedback, migration, or poor sound quality due to fit issues
Exclusion
- Participants who can only wear a size XXS (extra-extra small) extended wear device
- asymmetrical hearing loss
- other diagnosis that may cause hearing fluctuation
- inability to tolerate physical fit of Lyric devices
- inability to be seen for four lab visits
Key Trial Info
Start Date :
April 8 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04882800
Start Date
April 8 2021
End Date
June 15 2021
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Main Line Audiology Consultants
Narberth, Pennsylvania, United States, 19072